Sec. 303. Antimicrobial resistance
331 words·~2 min read·
/bill/118/s/1844/is/section-303·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than December 31, 2023, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report describing— activities conducted by the Center for Veterinary Medicine of the Food and Drug Administration (referred to in this section as the Center ) during the period of fiscal years 2019 through 2023 to support antimicrobial stewardship in veterinary settings, including ongoing activities and the targeted completion date of such activities; and with respect to antimicrobial stewardship in veterinary settings— the goals of the Center regarding supporting antimicrobial stewardship in veterinary settings; activities the Center plans to execute during the period of fiscal years 2024 through 2028 to support such goals, including targeted completion dates for such activities; and metrics the Center plans to use to evaluate progress toward its goals regarding supporting antimicrobial stewardship in veterinary settings.
Not later than 120 days after the end of each fiscal year during which fees are collected under section 740, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report that includes— a description of activities conducted by the Center in the prior fiscal year to support antimicrobial stewardship in veterinary settings, including progress made toward goals and activities specified in subsection (a)(2); in the case of an incomplete activity described in subsection (a)(2)(B) for which the target completion date has passed— an explanation for why such target completion date was not met; and if applicable, the updated expected completion date for such activity; a description of emerging challenges related to antimicrobial stewardship in veterinary settings that impact Center activities; and a description of activities undertaken to incentivize the development of new drugs for the treatment, prevention, or control of bacterial diseases in animals.